SIRT1 and colorectal carcinoma: This work demonstrates that inhibition or depletion of SIRT1 hampers the ability of 1,25(OH)2D3 to interfere Wnt/β-catenin target gene expression, and also the proliferation in CRC cells, thus providing a novel and crucial mechanism of the anti-CRC action of 1,25(OH)2D3.